Cars O, Mölstad S, Melander A
Lancet. 2001 Jun 9;357(9271):1851-3. doi: 10.1016/S0140-6736(00)04972-2.
Data on antibiotic use are not publicly available in most European Union countries. We obtained data for non-hospital antibiotic sales for 1997 from the 15 member states and analysed these according to the Anatomic Therapeutic Chemical classification system, and expressed them as defined daily doses per 1000 people per day. Sales of antibiotics varied more than four-fold: France (36.5), Spain (32.4), Portugal (28.8), and Belgium (26.7) had the highest sales, whereas the Netherlands (8.9), Denmark (11.3), Sweden (13.5), and Germany (13.6) had the lowest. There was also profound variation in use of different classes of antibiotics. Detailed knowledge of antibiotic use is necessary to implement national strategies for optimum antibiotic use, and to address the threat posed by resistant microorganisms.
在大多数欧盟国家,抗生素使用数据并非公开可得。我们获取了1997年15个成员国非医院抗生素销售的数据,并根据解剖治疗学化学分类系统进行分析,将其表示为每千人每天的限定日剂量。抗生素销售额相差四倍多:法国(36.5)、西班牙(32.4)、葡萄牙(28.8)和比利时(26.7)的销售额最高,而荷兰(8.9)、丹麦(11.3)、瑞典(13.5)和德国(13.6)的销售额最低。不同种类抗生素的使用也存在显著差异。了解抗生素使用的详细情况对于实施国家优化抗生素使用战略以及应对耐药微生物构成的威胁而言是必要的。